Enanta Pharmaceuticals logo
Enanta Pharmaceuticals ENTA
$ 11.25 -2.13%

Quarterly report 2024-Q2
added 08-07-2024

report update icon

Enanta Pharmaceuticals Balance Sheet 2011-2024 | ENTA

Annual Balance Sheet Enanta Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-58.9 M -18.7 M -51.9 M - -51 M -63.6 M -65.2 M -16 M -21.1 M -30.5 M -8.86 M -10.5 M -6.84 M

Long Term Debt

21.2 M 22.4 M 1.13 M - - - - - - - - - -

Long Term Debt Current

5.28 M 2.89 M 4.2 M 4.26 M - - - - - - - - -

Total Non Current Liabilities

- - - - 4.73 M 4.52 M 3.98 M 3.45 M 3.15 M 2.02 M 1.98 M 2.5 M 156 M

Total Current Liabilities

62.8 M 29.8 M 36.2 M 24.2 M 22.6 M 16 M 21 M 7.89 M 6.7 M 4.75 M 4.53 M - -

Total Liabilities

246 M 54.1 M 39.4 M 30.6 M 27.3 M 20.5 M 25 M 11.3 M 9.86 M 6.76 M 6.5 M 8.23 M 158 M

Deferred Revenue

- - - - - - - - - - 10 K 17 K -

Retained Earnings

-207 M -73.2 M 48.6 M 128 M 164 M 117 M 45.4 M 27.6 M 5.98 M -73 M -107 M -115 M -132 M

Total Assets

462 M 375 M 439 M 486 M 490 M 414 M 327 M 281 M 246 M 155 M 117 M 52.2 M 26.1 M

Cash and Cash Equivalents

85.4 M 44 M 57.2 M 87.1 M 51.2 M 63.9 M 65.7 M 16.6 M 21.7 M 30.7 M 8.86 M 10.5 M 6.84 M

Book Value

217 M 321 M 399 M 456 M 462 M 394 M 302 M 270 M 236 M 149 M 110 M 43.9 M -132 M

Total Shareholders Equity

217 M 321 M 399 M 456 M 462 M 394 M 302 M 270 M 236 M 149 M 110 M -115 M -132 M

All numbers in USD currency

Quarterly Balance Sheet Enanta Pharmaceuticals

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

48.1 M 43.4 M 20.5 M 21.2 M 22.3 M 23.1 M 21.9 M 22.4 M 22.2 M 15.1 M 16 M 1.13 M 1.64 M 1.13 M 3.52 M 3.84 M 3.84 M 3.84 M 5.99 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

250 M 247 M 237 M 246 M 257 M 57.1 M 46.7 M 54.1 M 47.2 M 48.2 M 56.2 M 39.4 M 32.6 M 39.4 M 29 M 30.6 M 30.6 M 30.6 M 28.7 M 27.3 M 27.3 M 27.3 M 27.4 M 20.5 M 20.5 M 20.5 M 23.1 M 25 M 25 M 25 M 10.2 M 11.3 M 11.3 M 11.3 M 14.1 M 9.86 M 9.86 M 9.86 M 21.7 M 6.76 M 6.76 M 6.76 M 4.58 M 6.5 M 6.5 M 6.5 M - 8.23 M 8.23 M - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 51 K 5 K 10 K 10 K 10 K - 17 K 17 K - - - - -

Retained Earnings

-294 M -272 M -240 M -207 M -179 M -140 M -102 M -73.2 M -46.8 M -15.1 M 18.5 M 48.6 M 73.2 M 48.6 M 119 M 128 M 128 M 128 M 177 M 164 M 164 M 164 M 143 M 117 M 117 M 117 M 57.1 M 45.4 M 45.4 M 45.4 M 22.7 M 27.6 M 27.6 M 27.6 M 32.2 M 5.98 M 5.98 M 5.98 M -31 M -73 M -73 M -73 M -113 M -107 M -107 M -107 M - -115 M -115 M - - - - -

Total Assets

399 M 414 M 428 M 462 M 495 M 326 M 348 M 375 M 385 M 407 M 441 M 439 M 450 M 439 M 481 M 486 M 486 M 486 M 511 M 490 M 490 M 490 M 454 M 414 M 414 M 414 M 341 M 327 M 327 M 327 M 278 M 281 M 281 M 281 M 278 M 246 M 246 M 246 M 215 M 155 M 155 M 155 M 110 M 117 M 117 M 117 M - 52.2 M 52.2 M - - - - -

Cash and Cash Equivalents

35.8 M 63.5 M 39.9 M 85.4 M 95.2 M 73.2 M 42.2 M 44 M 28.4 M 41 M 99.1 M 57.2 M 4.6 M 57.2 M 55.1 M 87.1 M 87.1 M 87.1 M 27.6 M 51.2 M 51.2 M 51.2 M 74.4 M 63.9 M 63.9 M 63.9 M 68.1 M 65.7 M 65.7 M 65.7 M 20.6 M 16.6 M 16.6 M 20.6 M 46.2 M 21.7 M 21.7 M 46.2 M 34.1 M 30.7 M 30.7 M 34.1 M 4.43 M 8.86 M 8.86 M 4.43 M 20.7 M 10.5 M 10.5 M 20.7 M - 6.84 M - -

Book Value

149 M 166 M 192 M 217 M 238 M 269 M 301 M 321 M 338 M 359 M 384 M 399 M 418 M 399 M 452 M 456 M 456 M 456 M 482 M 462 M 462 M 462 M 427 M 394 M 394 M 394 M 318 M 302 M 302 M 302 M 268 M 270 M 270 M 270 M 264 M 236 M 236 M 236 M 194 M 149 M 149 M 149 M 106 M 110 M 110 M 110 M - 43.9 M 43.9 M - - - - -

Total Shareholders Equity

149 M 166 M 192 M 217 M 238 M 269 M 301 M 321 M 338 M 359 M 384 M 399 M 418 M 436 M 452 M 456 M 452 M 452 M 482 M 482 M 482 M 482 M 427 M 427 M 427 M 427 M 318 M 302 M 302 M 318 M 268 M 270 M 270 M 270 M 264 M 236 M 236 M 236 M 194 M 149 M 149 M 149 M 106 M 110 M 110 M 110 M - -115 M -115 M - - -132 M - -

All numbers in USD currency